🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 12674W109
- Market Cap
- Small Cap
- IPO
- 10/25/2019 · $11.00/share
Business: Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. The Company's proprietary technology utilizes chimeric autoantibody receptor, or CAAR, T cells that are designed to selectively bind and eliminate B cells that produce disease-causing autoantibodies (pathogenic B cells) while sparing normal B cells.
Company Contact
- CEO
- Steven Nichtberger
- CFO
- Anup Marda
- Headquarters
- 2929 Arch Street, Suite 600 Philadelphia, PA 19104
- Phone
- 267-759-3100
- Investor Relations
- Anup Marda · 267-759-3100 · investors@cabalettabio.com